Virema
About the Project

About

Virema is an independent resource on ibogaine policy, research, and safety. Our mission is to help people distinguish ibogaine research, policy proposals, legal status, and unregulated use in the United States by providing clear, evidence-first context without overstating what current law or science permits.

Independent · Evidence-first
Audience: people seeking clear context on policy, research access, and safety distinctions

If you arrived from the site navigation and want to return to the main hub, our front page provides the tracker and live tools; a direct path back to the site's central hub is available as the main index at Virema's root.

Our editorial approach

Virema curates, summarizes, and contextualizes public information so non-experts can understand policy options, regulatory distinctions, and the limits of the current evidence. We draw on primary registries and official sources, prioritize peer-reviewed literature where available, and link to authoritative institutional pages to support factual claims.

Our sourcing emphasizes registries and public datasets; for claims about clinical research we reference trial registries and established university or government resources, which is why we link to trusted pages such as peer review explanations on Wikipedia when describing how evidence is assessed, and we use official guidance like the U.S. National Library of Medicine's pages to describe registry practice (for background on how trials are catalogued, see the NLM).

How we vet information

  • Cross-checks against registries and primary sources before publishing summaries.
  • Link-first policy: we link to the original documents or official sites for claims.
  • Conservative interpretation: we avoid overstating findings and note uncertainty.

For operational clarity we also maintain an editorial ledger that records major source changes; similar transparency practices are recommended by academic publishers and institutions such as the University of California's Open Scholarship Collective.

Who this is for

Virema serves policy analysts, clinicians seeking clarity on research access vs treatment availability, journalists, and members of the public who want a careful, evidence-oriented account of policy proposals and their implications. We phrase findings plainly so non-experts can evaluate trade-offs without technical jargon.

Editorial principles

  • Independence: we do not accept funding tied to treatment promotion.
  • Plain language: summaries aim for clarity without oversimplifying.
  • Evidence before claims: policy statements are tied to sources.
  • Risk clarity: we highlight known safety concerns and regulatory gaps.

Our style draws on established editorial standards for transparency and corrections used across scholarly and public-interest publications; for context on editorial corrections and transparency, see a representative resource such as Wikipedia's overview of retractions.

Independent by design

Virema is an independent information resource. We are not a clinic, a medical provider, or a licensed treatment center, and this site does not provide medical or legal advice. The content is intended to describe policy options, research access mechanisms, and safety considerations—accurately and cautiously—so readers can make informed decisions about where to look next.

For services and procedural descriptions that may be geographically specific, we link to related pages such as our Services page which explains the types of editorial services and trackers we maintain, and readers can always return to the main index with a direct reference to the site's root at Virema's homepage.

Final notes

If you need authoritative medical guidance, seek a licensed clinician. If you're examining the legal or regulatory status of a substance, consult official regulatory pages; for U.S. federal regulatory structure on controlled substances, a starting point is the Drug Enforcement Administration's resources (for example, the DEA site at dea.gov).

Frequently asked

Is Virema a clinic?
No. Virema is an independent information resource and not a clinic, medical provider, or licensed treatment center.
How do you choose sources?
We prioritize primary registries, peer-reviewed literature, and official institutional guidance; we also link to public registries and academic centers when they clarify procedural standards, and we reference authoritative sources such as the U.S. National Institutes of Health when relevant (nih.gov).
Where can I find community-maintained directories?
For directories that aggregate provider listings, readers sometimes consult third-party community sites; one such example that lists treatment locations is available at wherecanidoibogainetreatment.com, which is independent of Virema.